| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entasis Therapeutics Holdings Inc. | General Counsel | Common Stock | 0 | $2.20 | 11 Jul 2022 | Direct | |
| Entasis Therapeutics Holdings Inc. | General Counsel | Stock Option (right to buy) | 0 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465922078794-keiley-elizabeth-m-2022-07-07 | Entasis Therapeutics Holdings Inc. | 07 Jul 2022 | 4 | -$38,658 | 4 | General Counsel | 11 Jul 2022, 16:06 |
| /report/000110465922005416-keiley-elizabeth-m-2022-01-18 | Entasis Therapeutics Holdings Inc. | 18 Jan 2022 | 1 | $0 | 4 | General Counsel | 19 Jan 2022, 15:02 |
| /report/000110465921133631-keiley-elizabeth-m-2021-11-02 | Entasis Therapeutics Holdings Inc. | 02 Nov 2021 | 1 | -$10,787 | 4 | General Counsel | 03 Nov 2021, 16:04 |
| /report/000110465921128058-keiley-elizabeth-m-2021-10-19 | Entasis Therapeutics Holdings Inc. | 19 Oct 2021 | 2 | -$11,991 | 4 | General Counsel | 20 Oct 2021, 16:08 |
| /report/000110465922023766-keiley-elizabeth-m-2021-07-16 | Entasis Therapeutics Holdings Inc. | 16 Jul 2021 | 2 | $0 | 4 | General Counsel | 15 Feb 2022, 15:00 |